Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis
- PMID: 33654683
- PMCID: PMC7907796
- DOI: 10.1007/s40200-021-00768-5
Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis
Abstract
Background: Currently, the number of patients with SARS-COV-2 infection has increased rapidly in Iran, but the risk and mortality of SARS-COV-2 infection in Iranian patients with diabetes mellitus (DM), chronic kidney disease (CKD), hypertension and cardiovascular diseases (CVDs) still not clear. The aim of this meta-analysis was to estimate the proportion and mortality of SARS-COV-2 in these patients.
Methods: A comprehensive literature search was carried out in PubMed, Web of Sciences, Cochrane Library, EMBASE, CNKI, SciELO, and other databases to identify all relevant studies published up to 10 January, 2020. The proportion and mortality in the patients were assessed by odd ratio (OR) and the corresponding 95 % confidence interval (95 % CI).
Results: A total of ten case-series including 11,755 cases with SARS-COV-2 infection and 942 deaths were selected. Among them, there were total of 791 DM patients with 186 deaths, 225 CKD patients with 45 deaths, 790 hypertension cases with 86 deaths, and 471 CVDs cases with 60 deaths. Pooled data revealed that the proportion of SARS-COV-2 infection in the patients with hypertension, DM, CVDs and CKD were 21.1 %, 16.3 %, 14.0 % and 5.0 %, respectively. Moreover, the SARS-COV-2 infection were associated with an increased risk of mortality in DM (OR = 0.549, CI 95 % 0.448-0.671, p ≤ 0.001) and CKD (OR = 0.552, 95 % CI 0.367-0.829, p = 0.004) patients, but not hypertension and CVDs. There was no publication bias.
Conclusions: Our pooled data showed that the proportion of SARS-COV-2 infection was the highest in the Iranian patients with hypertension (21.1 %) followed by DM (16.3 %), CVDs (14.0 %) and CKD (5.0 %). Moreover, DM and CKD in patients with SARS-COV-2 infection were associated with a 0.549 and 0.552-fold increase in mortality, respectively. Clinicians in Iran should be aware of these findings, to identifying patients at higher risk and inform interventions to reduce the risk of death. Moreover, well-designed, large-scale and multicenter studies are needed to improve and validate our findings.
Keywords: COVID-19; Cardiovascular disease; Chronic kidney disease; Diabetes; Hypertension; SARS-COV-2.
© Springer Nature Switzerland AG 2021.
Conflict of interest statement
Conflicts of interest/Competing interestsThe authors declare that they have no conflict of interest.
Figures







Similar articles
-
Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.J Korean Med Sci. 2021 Jan 11;36(2):e15. doi: 10.3346/jkms.2021.36.e15. J Korean Med Sci. 2021. PMID: 33429474 Free PMC article.
-
Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.Aging Male. 2020 Dec;23(5):1416-1424. doi: 10.1080/13685538.2020.1774748. Epub 2020 Jun 8. Aging Male. 2020. PMID: 32508193
-
Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis.Arch Med Res. 2020 Oct;51(7):700-709. doi: 10.1016/j.arcmed.2020.07.005. Epub 2020 Aug 7. Arch Med Res. 2020. PMID: 32811670 Free PMC article.
-
Risk factors for mortality in COVID-19 patients in sub-Saharan Africa: A systematic review and meta-analysis.PLoS One. 2022 Oct 17;17(10):e0276008. doi: 10.1371/journal.pone.0276008. eCollection 2022. PLoS One. 2022. PMID: 36251715 Free PMC article.
-
Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis.Hematol Transfus Cell Ther. 2022 Apr-Jun;44(2):225-234. doi: 10.1016/j.htct.2021.09.020. Epub 2021 Dec 15. Hematol Transfus Cell Ther. 2022. PMID: 34931178 Free PMC article. Review.
Cited by
-
Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International Study.J Clin Med. 2021 Dec 14;10(24):5863. doi: 10.3390/jcm10245863. J Clin Med. 2021. PMID: 34945166 Free PMC article.
-
Adherence to the Mediterranean Diet Association with Serum Levels of Nitric Oxide, Prostacyclin, and Thromboxane B2 among Prinzmetal Angina Patients and Healthy Persons.Nutrients. 2023 Feb 1;15(3):738. doi: 10.3390/nu15030738. Nutrients. 2023. PMID: 36771443 Free PMC article.
-
Association of ACE I/D and PAI-1 4G/5G polymorphisms with susceptibility to type 2 diabetes mellitus.J Diabetes Metab Disord. 2021 Jul 3;20(2):1191-1197. doi: 10.1007/s40200-021-00839-7. eCollection 2021 Dec. J Diabetes Metab Disord. 2021. PMID: 34900771 Free PMC article.
-
A meta-analysis for the risk and prevalence of preeclampsia among pregnant women with COVID-19.Turk J Obstet Gynecol. 2021 Sep 27;18(3):224-235. doi: 10.4274/tjod.galenos.2021.66750. Turk J Obstet Gynecol. 2021. PMID: 34580872 Free PMC article.
-
Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19.Turk J Obstet Gynecol. 2021 Sep 27;18(3):236-244. doi: 10.4274/tjod.galenos.2021.74829. Turk J Obstet Gynecol. 2021. PMID: 34580931 Free PMC article.
References
-
- Noorishadkam M, Lookzadeh MH, Mazaheri M, Mirjalili SR, Bahrami R, Asadian F, et al. Coronavirus disease 2019 (COVID-19) and late pregnancy loss in infected pregnant women: a mini review. World J Peri Neonatol. 2020;2:67–70.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous